Rating: 4.5 / 5 (9309 votes)
Downloads: 18155
>>>CLICK HERE TO DOWNLOAD<<<
91 mg/ lb ( 2 mg/ kg) body weight. each tablet is formulated to provide a minimum sarolaner dosage of 0. simparica may cause neurologic signs such as tremors, unsteadiness and/ or seizures in dogs with or without a history of neurologic disorders. simparica tablets are chewable and palatable and readily consumed by dogs when offered by the owner. simparica trio ( sarolaner, moxidectin, and pyrantel chewable tablets) is a flavored, chewable simparica pdf tablet for administration to dogs 8 weeks of age and older. if the tablet is not taken up voluntarily by the dog it can also be given with food or directly into the mouth. 2 mg/ kg) sarolaner, 0. simparica | zoetis petcare what a flea infestation looks like important safety information: see pdf prescribing information. 011 mg/ lb ( 24 µg/ kg) moxidectin, and 2. simparica is for use only in dogs 6 months of age and older. each tablet is formulated to provide minimum dosages of 0.
27 mg/ lb ( 5 mg/ kg) pyrantel ( as pamoate salt). in laboratory safety studies, no interactions were observed when sarolaner was co- administered with milbemycin oxime, moxidectin and pyrantel pamoate. the tablets should not be divided. during clinical field trials, no interactions between simparica chewable tablets for dogs and routinely used veterinary medicinal products were observed. description: simparica is a flavored, chewable tablet for administration to dogs over 6 months of age according to their weight.
留言列表
